FGF23 and hypophosphatemia: Since hypophosphatemia is induced by FGF23 but not by other ligands for FGFR1 [246]—the main phosphate-regulating FGFR—cotreatment with recombinant FGF23 is one approach that could, in theory, mitigate this toxicity.